Medrad公司推出MR兼容注射系统

 
一种核磁共振(MR)兼容的infusion系统现在可以用于高达3.0特斯拉(T)的磁场能量。

Medrad公司(Indianola, PA, USA)最近获得了美国食品药品管理局(FDA)对该公司Continuum MR注射系统的许可，该系统可以在最高包括3.0T磁场环境中使用。FDA的许可允许临床医生在3.0T环境中注射药物、镇静催眠药、以及其他利用Continuum MR便捷操作和剂量增强功能的药物。

 
MR-Compatible Infusion System
 
A magnetic resonance- (MR)-compatible infusion system can now be used for magnet strengths up to 3.0 Tesla (T).

Medrad, Inc. (Indianola, PA, USA) has received U.S. Food and Drug Administration (FDA) clearance for use of its Continuum MR infusion system in MR environments up to and including 3.0T. The new FDA clearance enables clinicians working in the latest 3.0T environments to infuse medications, sedatives, and other drugs while benefiting from Continuum’s ease-of-use and dose enhancements.